Quarterly Results • Search Archive
Ind-Swift Laboratories Limited
Results, Financials & Updates
Follow Ind-Swift Laboratories Limited results and financial updates in one company page: latest revenue or income, profit, margins, quarter comparisons, what changed and detailed Nivata Results deep dives.
1 published deep dive
1 quarter 1 sector
Company Overview
Ind-Swift Laboratories Limited: latest results and financials
About the business in Nivata's latest coverage
Ind-Swift Laboratories Limited operates in the pharmaceutical sector, focusing primarily on the research, development, and manufacturing of active pharmaceutical ingredients (APIs), advanced intermediates, and finished dosage formulations. The company serves global pharmaceutical markets, supplying regulatory-compliant chemical entities and pharmaceutical ingredients. The company's primary business model revolves around large-scale API manufacturing backed by in-house R&D and chemical synthesis capabilities. It sells its products across domestic and international markets, catering to generic drug manufacturers and branded pharmaceutical companies worldwide.
Quarter history
Ind-Swift Laboratories Limited Results & Financials
Latest Nivata coverage: Q2 FY27 · revenue ₹240.46 Cr · PAT ₹34.22 Cr.
Nivata currently has one covered quarter for this company. This page remains the stable company-results hub and expands automatically as additional quarters are published.